Hans-Heinrich Oberg Selected Research

Hans-Heinrich Oberg Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 11/2009
8	Adenocarcinoma 01/2020 - 11/2009
3	Infections 01/2020 - 01/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 06/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 09/2007
2	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2018
2	Carcinogenesis 01/2017 - 03/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2017
1	Multiple Myeloma 09/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Glioma (Gliomas) 04/2016
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Pancreatic Diseases (Pancreatic Disease) 01/2014
1	Carcinoma (Carcinomatosis) 10/2013
1	Polyps 11/2012
1	Hypersensitivity (Allergy) 06/2011
1	Asthma (Bronchial Asthma) 02/2008
1	Crohn Disease (Crohn's Disease) 02/2008
1	Atopic Dermatitis (Atopic Eczema) 02/2008
1	Rheumatoid Arthritis 04/2006
1	Autoimmune Diseases (Autoimmune Disease) 04/2006

Drug/Important Bio-Agent (IBA)

9	LigandsIBA 01/2022 - 11/2009
6	AntigensIBA 01/2022 - 01/2014
5	Bispecific AntibodiesIBA 01/2020 - 01/2014
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 03/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2016
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 04/2016
3	PlatinumIBA 01/2020 - 06/2013
3	Metalloproteases (Metalloproteinases)IBA 03/2018 - 10/2013
3	DisintegrinsIBA 03/2018 - 10/2013
2	AntibodiesIBA 01/2022 - 09/2017
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2014
2	Granzymes (Granzyme)IBA 01/2019 - 11/2009
2	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2017 - 04/2016
2	micaIBA 04/2016 - 10/2013
2	Diphosphates (Pyrophosphates)IBA 07/2015 - 03/2013
1	human ERBB2 proteinIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Fc Receptors (Fc Receptor)IBA 01/2021
1	CytokinesIBA 01/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	Galectins (Galectin)IBA 11/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	KynurenineIBA 01/2020
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2019
1	PerforinIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	AmphiregulinIBA 03/2018
1	Immunoglobulin Fab FragmentsIBA 01/2018
1	blinatumomabIBA 11/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	SteroidsIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 11/2016
1	Temozolomide (Temodar)FDA LinkGeneric 04/2016
1	Diphosphonates (Bisphosphonates)IBA 07/2015
1	NitrogenIBA 07/2015
1	ProstaglandinsIBA 03/2015
1	Ligases (Synthetase)IBA 03/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2015
1	VimentinIBA 01/2014
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2014
1	EnzymesIBA 10/2013
1	ImmunosorbentsIBA 10/2013
1	Angiopoietin-2IBA 06/2013
1	Phosphotransferases (Kinase)IBA 06/2013
1	Sunitinib (Sutent)FDA Link 06/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013
1	Surface Antigens (Surface Antigen)IBA 03/2013
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2012
1	Histocompatibility Antigens Class IIBA 11/2009
1	NK Cell Lectin-Like Receptor Subfamily CIBA 11/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2009
1	Poly I-CIBA 11/2009
1	Toll-Like Receptor AgonistsIBA 11/2009
1	Imiquimod (Aldara)FDA LinkGeneric 11/2009
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 02/2008
1	Leucine (L-Leucine)FDA Link 02/2008
1	Terpenes (Terpenoids)IBA 01/2008
1	Pattern Recognition ReceptorsIBA 01/2008
1	Mevalonic Acid (Mevalonate)IBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 09/2007
1	Small Interfering RNA (siRNA)IBA 09/2007
1	Interleukin-8 (Interleukin 8)IBA 09/2007
1	Proteins (Proteins, Gene)FDA Link 04/2006

Therapy/Procedure

13	Immunotherapy 01/2021 - 11/2009
4	Therapeutics 01/2020 - 12/2012
2	Drug Therapy (Chemotherapy) 03/2018 - 01/2014
1	Resistance Training 03/2018
1	Adjuvant Chemotherapy 03/2018
1	Chemoradiotherapy 01/2017
1	Ligation 07/2011
1	Organ Transplantation 06/2011